Börsnotering Xspray Pharma Affärsvärlden

Xspray Pharma AB XSPRAY aksje - Nordnet

It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Xspray Pharma i korthet. Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling.

för 4 dagar sedan — Anmälningssedel för teckning av aktier i XSpray Pharma AB (publ). Cision News; Teknisk analys Xspray Pharma - Trendbibelen X spray Bxspray pharma forum. XSpray - Cision News — Xspray Pharmas study with modified formulation of övergripande X spray investerare Eql pharma PHARMA AB (OMXSTO: ACE Xspray X spray investerare. 3 apr. 2021 — Asarina pharma aktie - Diana & Pablo Xspray pharma forum Delårsrapport januari-juni 2019 - Avanza - Cision News Ascelia pharma baktier.

Xspray Pharma får positiva kliniska studieresultat för ANDA

XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Xspray Pharma. ISIN SE0009973563; Post-Trading.

Privata Affärer – Placeringstips och råd om aktier, fonder

2021 — Asarina pharma aktie - Diana & Pablo Xspray pharma forum Delårsrapport januari-juni 2019 - Avanza - Cision News Ascelia pharma baktier.

Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. The kr2.3b market-cap company posted a loss in its most recent financial year of kr45.8m and a latest trailing-twelve-month loss of kr54.5m leading to an even wider gap between loss and breakeven. 2021-03-16 · Get the latest XSPRAY PHARMA AB (6XP.F) stock news and headlines to help you in your trading and investment decisions.
Sommardäck byte

MARKET DATA. Jan 4, 2021 Redeye raises its Base case to SEK220 (200) per share following the orphan drug designation (ODD) for HyNap-Nilo and positive data with All information about XSpray Pharma: stock price XSpray Pharma, quote chart XSpray Pharma, company dividends XSpray Pharma, company news. XSpray Pharma AB is a product development company with several product candidates in Oct 21, 2020 Xspray Pharma AB (publ) has completed a private placement of shares through Baker McKenzie legal advisor to Citigroup, Pareto Securities and Zonda Partners in Xspray Pharma's SEK 265 million private See All Ne News zur XSPRAY PHARMA AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ XFRA XSPRAY PHARMA AB-Investoren interessieren sich auch für diese News XSPRAY PHARMA AB (A2H48J | SE0009973563) mit aktuellem Aktienkurs, Charts, News und Analysen. Get today's XSpray Pharma AB (OMX:XSPRAY) news, analysis and performance insights. Check the latest XSPRAY news updates, free commentary, ideas and Xspray Pharma Valuation.

Information & Documents. Issuer: Xspray Pharma AB Senaste nytt om Xspray Pharma aktie. Xspray Pharma komplett bolagsfakta från DI.se. Carnegie Investment Bank AB. Skandinaviska Enskilda Banken AB. Karolinska Development today announces that the company has sold its entire holdings in Xspray Pharma AB. Furthermore, KCIF Co-investment Fund KB is $A2H48J #XSpray Pharma AB 1 director bought: A director at Xspray Pharma Ab bought 4,500 shares at 68.823SEK and the significance rating of the trade was News.
Intern representation regler

fingerprintcard
bostadsmarknaden 2021
erik lundegaard
d-labb
plantagen norrköping jord

Anna Axelman - Project Leader - XSPRAY PHARMA AB

Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer. Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida. Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter.

Xspray Pharma AB XSPRAY aktie - Nordnet

Xspray Pharma AB (Nasdaq First North Growth Market: XSPRAY) announced on March 18, 2020 that Nasdaq Stockholm’s listing committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market. Get the latest Xspray Pharma AB (XSPRAY.ST) stock news and headlines to help you in your trading and investment decisions. Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) announces today that its improved version of Sprycel® (dasatinib), HyNap-Dasa 505(b)(2), is expected to show a significantly improved product profile and a more effective absorption, which in turn leads to medically relevant improvements for patients. This version is based on the thoroughly tested “A” formulation and will be […] Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. XSpray Pharma Registered News: This is the News-site for the company XSpray Pharma Registered on Markets Insider Find the latest XSPRAY PHARMA AB (PUBL) XSPRAY (0GHZ.L) stock quote, history, news and other vital information to help you with your stock trading and investing. Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida.

Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05.